IMS Health acquires HGS Europe

Share this article:

IMS Health brought market access firm HGS Europe into the fold last month.

The UK company, which was founded in 1998 by Angela and Graeme McFarland, has expertise in understanding the market access piece of a launch as well as what cost-effectiveness ­gatekeepers such as NICE are looking for.

Mike Sanvoisin, the GM of UK and Ireland for IMS, told MM&M that IMS will be looking to link its own real-world data assets with HGS's strategies in order to help European payers see how drugs are performing in the real world. “Payers want to see that investments they make are having an effect,” Sanvoisi said. “That's where we see the synergy of HGS coming in.”

Share this article:

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"